REV-ERBβ is required to maintain normal wakefulness and the wake-inducing effect of dual REV-ERB agonist SR9009

Jan 23, 2018Biochemical pharmacology

REV-ERBβ is needed for normal wakefulness and for the wake-promoting effect of the drug SR9009

AI simplified

Abstract

REV-ERBβ deficiency is associated with altered gene expression and impaired maintenance of wakefulness.

  • Circadian signaling influences various physiological and behavioral processes, including sleep and wakefulness.
  • REV-ERBβ is implicated in maintaining wakefulness during the activity period.
  • Mice lacking REV-ERBβ did not exhibit increased wakefulness when treated with a specific REV-ERB agonist.
  • Gene expression related to sleep and wakefulness is altered in mice deficient in REV-ERBβ.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free